(MSLI) (MSLI) Stock Price, News & Analysis

Company Overview

Merus Labs International Inc. is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products. The Company's products include Elantan, Isoket, Deponit, Sintrom, Emselex/Enablex, Surgestone, Provames, Speciafoldine, Tredemine, Salagen, Estraderm MX and Vancocin. Elantan are tablets or capsules that belong to a group of medicines called organic nitrates. Isoket belongs to a group of medicines called organic nitrates. Deponit belongs to a group of medicines called nitrates. Sintrom is an anticoagulant indicated to treat and prevent thromboembolic diseases. Emselex/Enablex is used in adults to treat overactive bladder syndrome. Surgestone is used to treat women with menstrual irregularities due to ovulation disorder, dysmenorrhea and premenstrual syndrome. Provames is used as hormone replacement therapy in postmenopausal women with symptoms of estrogen deficiency.

Key Stats

• Today's Range: $1.30 to $1.30
• 50-Day Range: N/A
• 52-Week Range: $0.70 to $1.33
• Volume: N/A
• Average Volume: 56,140 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MSLI Stock Analysis - Frequently Asked Questions

How were (MSLI)'s earnings last quarter?

(MSLI) (NASDAQ:MSLI) posted its quarterly earnings results on Monday, August, 10th. The company reported ($0.01) earnings per share for the quarter, missing analysts' consensus estimates of $0.02 by $0.03. The firm had revenue of $7.73 million for the quarter, compared to the consensus estimate of $17.19 million.

What other stocks do shareholders of (MSLI) own?

Based on aggregate information from My MarketBeat watchlists, some other companies that (MSLI) investors own include ProMetic Life Sciences (PLI), Palatin Technologies (PTN), Anavex Life Sciences (AVXL), Biocept (BIOC), Can-Fite BioPharma (CANF), InterCloud Systems (ICLD) and Merus Labs International (MSL).

Company Calendar

• Last Earnings: 8/10/2015
• Today: 2/22/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:MSLI
• CUSIP: N/A
• CIK: 1031516
• Web: www.meruslabs.com
• Phone: +1-905-7260995
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A